Trust Size
$524M
Peak Price
$896.94
Current Price
$72.14
Return
+621.4%
What Happened
GeneDx Holdings Corp. filed its S-1 registration in 2020 and completed its business combination in 2022. The company remains actively traded with 732 SEC filings on record.
GeneDx Holdings Corp. entered the SPAC market in 2020 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
The company filed a definitive proxy statement (DEFM14A) ahead of its merger vote, completing its de-SPAC transaction in 2022.
SEC records show 732 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2020-08-24
S-1 Registration Filed
2022-03-31
Merger Proxy Filed (DEFM14A)
SEC Filing Details
CIK Number
1818331
Total SEC Filings
732
State of Incorporation
DE
Last Filing Date
2026-03-17
Business Location
New York, NY
Trust/Asset Size
$524M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for GeneDx Holdings